MAX LYON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Theriva Biologics, Inc.

Filing Date Source Excerpt
2009-11-20 Max Lyon 65 Chief Executive Officer and President 2009. On June 26, 2009 the Company's Board of Directors approved a compensation package with our current Chief Executive Officer and President, Max Lyon. Mr. Lyon is entitled to an annual base salary of $190,000 and is eligible for discretionary performance and transactional bonus payments.

Data sourced from SEC filings. Last updated: 2026-02-03